Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair [NA]
A completed clinical trial evaluating the efficacy and safety of a standardized botanical nutraceutical for thinning hair in peri-menopausal…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Clinical Evaluation of Localized Scalp Thread Embedding for Male Androgenetic Alopecia [NA]
Clinical trial update reporting completion of a study evaluating localized scalp thread embedding for male androgenetic alopecia.
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia [NA]
The document reports a terminated clinical trial evaluating biological and biometrological parameters in adults with androgenetic alopecia. …
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: Development and Standardization Methods
Clinical trial focusing on development and standardization methods for a treatment targeting androgenetic alopecia has completed.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers [NA]
Update on a six-month single-blind, placebo-controlled trial evaluating a hair growth dietary supplement in 45 volunteers with androgenetic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Treatment of Androgenetic Alopecia in Men for 24 Weeks [Phase 3]
The document reports completion of a Phase 3 trial evaluating a treatment for androgenetic alopecia in men over 24 weeks.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Various Procedural Treatment Options for Androgenetic Alopecia [Phase 2]
This entry reports a Phase 2 clinical trial evaluating various procedural treatment options for androgenetic alopecia that has not yet start…
-
CLINICAL_TRIALS withdrawal · 2025-02-06Clinical Trial Update: Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia [NA]
This clinical trial evaluating Plasma Rich in Growth Factors (PRGF-Endoret) for androgenetic alopecia was withdrawn before completion, with …
-
CLINICAL_TRIALS withdrawal · 2025-01-27Clinical Trial Update: Hydraderm for Androgenic Alopecia [Phase 4]
A Phase 4 clinical trial of Hydraderm for androgenetic alopecia has been withdrawn.
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia. [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/Phase 2 evaluation of allogeneic mesenchymal stem cell therapy for hair regrowth in and…
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss [Phase 3]
This entry describes a Phase 3 clinical study evaluating DA-002 and DA-005 for hair loss conditions, including androgenetic alopecia and mal…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study
A retrospective study comparing the efficacy of platelet-rich plasma versus mesotherapy for androgenetic alopecia.
-
FDA approval · 2024-11-26FDA Approved: MINOXIDIL TOPICAL SOLUTION 2% — Original Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approves the original ANDA for Minoxidil Topical Solution 2% from Sun Pharmaceutical Industries, establishing a generic version of the 2…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Umbilical Cord-derived Mesenchymal Stem Cell Exosomes on Hair Growth in Patients With Androgenetic Alopecia [NA]
A clinical trial update notes an ongoing study evaluating umbilical cord-derived mesenchymal stem cell exosomes for hair growth in androgene…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males [Phase 2]
Phase 2 trial assessing GT20029 solution for androgenetic alopecia in Chinese adult males has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia [Phase 2]
Phase 2 trial comparing exosome therapy to platelet-rich plasma for androgenetic alopecia has completed; the snippet does not provide specif…
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia [Phase 2, Phase 3]
Clinical trial update for TopicalKX-826 Solution in Chinese male patients with androgenetic alopecia. Phase 2 and Phase 3 studies are not ye…
-
CLINICAL_TRIALS withdrawal · 2024-10-15Clinical Trial Update: Clinical Study of Probiotic Treatment for Androgenetic Alopecia [Phase 3]
A Phase 3 clinical trial evaluating a probiotic treatment for androgenetic alopecia has been withdrawn.
-
EMA safety_alert · 2024-10-04Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2024
PRAC has initiated a safety review of medicines containing finasteride and dutasteride to assess potential safety concerns. The review cover…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia. [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of daily topical dutasteride in men with androgenetic alopecia has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects [Phase 1]
Phase I trial evaluating safety, tolerability, and pharmacokinetics of CU-40101 Liniment in adult male androgenetic alopecia subjects has be…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: To Evaluate the Safety, Tolerability and Efficacy in Male and Female with AGA Treated with HMI-115 Over a 24-week Treatment Period [Phase 1]
Phase 1 trial evaluating the safety, tolerability, and preliminary efficacy of HMI-115 in male and female participants with Androgenetic alo…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss [NA]
This clinical trial update concerns a cosmetic anti-hair loss treatment for men with androgenetic alopecia. The study status is not yet recr…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Modulated Light Therapy in Participants With Pattern Hair Loss [NA]
Clinical trial evaluating modulated light therapy for androgenetic alopecia has completed and results have been posted.
-
FDA label_change · 2024-08-22FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approves a supplemental application for finasteride from Accord Healthcare, Inc., resulting in labeling changes.